1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services, including organ transportation through its fleet of 18 aircraft. » Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read More
Market Commentary: 1 Unlikely AI Play You Should Not Ignore
When you think of AI plays, Airbnb is not the first company that springs to mind. Yet, Brian Chesky’s firm has made a splash by snapping up GamePlanner.ai for $200 million.
Although it’s not apparent at first glance how artificial intelligence plays into the Airbnb business model, a deeper dive reveals the genius behind the acquisition.
» Read more about: Market Commentary: 1 Unlikely AI Play You Should Not Ignore »
Read More
Market Commentary: Insiders Think This Stock Is a Steal
As a prominent mall REIT, Simon Property Group (SPG) share price has been doubly impacted by both the rise of remote work and the surge in online retail, leading to its dividend yield soaring to an impressive 6.5%.
This high yield has prompted a significant change in management’s investment strategy, now favoring the repurchase of SPG shares.
» Read more about: Market Commentary: Insiders Think This Stock Is a Steal »
Read More
Market Commentary: Is This Stock The Next Starbucks?
Imagine your job is to grow Starbucks. You’ve got your work cut out for you launching hundreds of store locations each year in prime locations. Market research, consumer trends, cost of real estate, these are just a few of the factors you’ll need to analyze before building out the stores, and then you’ve got all the challenges of hiring baristas,
» Read more about: Market Commentary: Is This Stock The Next Starbucks? »
Read More
Is Tesla In Nose-Bleed Territory?
Tesla has had a scintillating run since Election Day with the stock rallying from the low $220 region all the way towards $350+ in a matter of days.
Having run so far so fast, what are the odds Tesla share price is set to correct soon? How high is too high for Tesla stock price?
» Read more about: Is Tesla In Nose-Bleed Territory? »
Read MoreThe Ivy
Is Buffett Primed To Pounce On a Crash?
In 2024, value investing legend Warren Buffett did the seemingly unthinkable by selling stocks aggressively in a year that saw the S&P 500 climb by about 23 percent.
While the exact figures on Buffett’s selling won’t be known until Berkshire Hathaway releases its Q4 earnings report, the total stood at a staggering $133 billion as of the end of Q3.
» Read more about: Is Buffett Primed To Pounce On a Crash? »
Read MoreThe Spotlight
How To Blow $3 Billion
Among the many rules of business is be careful in whose playground you are competing. Gaming companies learned this the hard way a few years ago when they built their businesses on top of the Facebook platform. So too did media companies like PopSugar. When Facebook decided to focus more on surfacing individual posts over corporate ones,
» Read more about: How To Blow $3 Billion »
Read MoreThe Daily
Federal Reserve ends enforcement action vs. Illinois bank
Andrew Harrer/Bloomberg
The Federal Reserve has ended an enforcement action against a small Illinois bank and its holding company.
The Fed Board ended its written agreement with Perry County Bancorp and its subsidiary, Du Quoin-based Du Quoin State Bank last week. The move,
» Read more about: Federal Reserve ends enforcement action vs. Illinois bank »